Additionally, a recent review describes the potential utilization of both MRI and CT techniques in order to image and diagnose breast cancer brain metastases; [37] this may be of particular interest for a HER-2 targeted imaging conjugate since HER-2 positive cancers are more aggressive [22]. Here, ERBB2 is linked to breast carcinoma.